Sánchez-Rodríguez G, Luévanos-Gurrola K, Ramírez-Cázares AC, Rodríguez-Bonito R, Rodríguez-Balderrama I

Language: Spanish
References: 12
Page: 50-53
PDF size: 215.74 Kb.

ABSTRACT

The use of misoprostol is contraindicated in pregnancy because of its potential as an abortifacient and its relationship with malformations such as microcephaly, Möbius syndrome and clubfoot, among other complications. We present two cases of patients with malformations evident at term birth with a history of misoprostol intake by the mother in the first trimester. The use of misoprostol in countries where abortion is illegal increases its misuse with the consequent appearance of newborns with various congenital malformations. It is important to disseminate and understand the teratogenic effects of this drug, as well as the control of its use.

REFERENCES

1. Goldberg A, Greenberg M, Darney P, Misoprostol and pregnancy. New England J Med 2001; 341: 38-47.

2. Philip N, et al. Misoprostol y teratogenicidad: Revisión de la evidencia Informe de una reunión organizada por el Population Council New York, New York 22 de mayo de 2002, 1-25.

3. Da Silva T, et al. Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies. Cad Saúde Pública Rio de Janeiro 2008; 24: 1447-53.

4. Isaza C, et al. Uso inadecuado de misoprostol. ¿Un problema de salud pública? Colomb Med 2008; 39 (Suppl. 2).

5. Satro-Opaleye E, Luna-Cohelo H, Shüler-Faccini L, et al. Evaluation of the teratogenic risks in gestations exposed to misoprostol. Rev Bras Ginecol Obstet 2010; 32: 19-25.

6. Pastuszak L, Schüler L, Speck-Martins C, et al. Use of Misoprostol during pregnancy and Moebius Syndrome in Infants. N Engl J Med 1998; 338: 1881-5.

7. Pirmez R, Freitas MET, Gasparetto EL, Araujo APQC, Moebius syndrome and holoprosencephaly following exposure to misoprostol. Pediatr Neurol 2010; 43: 371-3.

8. Nobuko K, Katsuyoshi K, Tomohiro K, Makoto H, Tadao A. A case of Moebius syndrome presenting with congenital bilateral vocal cord paralysis. Eur J Pediatr 2007; 166: 831-3.

9. Gonzalez H, Marques-Dias MJ, Kim A, Sugayama M, Da Paz JA, Huson SM, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998; 351: 1624-27.

10. Akoury A, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris E. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation. Am J Obstet Gynecol 2004; 190: 755e62.

11. Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VFA, Sugayama SMM, et al. Prenatal exposure to misoprostol an vascular disruption defects: a casecontrol study. Am J Med Genet 2000;95: 302-6.

12. Dal TdS, Pozzobon F, Serrate S. Prenatal exposure to misoprostol and congenital anomalies: Systematic review and meta-analysis. Reprod Toxicol 2006; 22: 666-71.